Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,159,872 papers from all fields of science
Search
Sign In
Create Free Account
magnesium orotate
Known as:
Magnesium 2,6-Dioxo-3H-Pyrimidine-4-Carboxylate
, Orotate Magnesium
, Orotic Acid, Magnesium Salt
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Orotic Acid
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
EFFECT OF MAGNESIUM OROTATE ON CONNECTIVE TISSUE MATRIX AND CARDIAC INOTROPIC FUNCTION IN PATIENTS WITH MITRAL VALVE PROLAPSE. CLINICAL AND MORPHOLOGICAL STUDY
A. Avtandilov
,
K. M. Dzeranova
,
T. G. Borovaya
,
L. Didenko
2013
Corpus ID: 73973853
Aim. To study the morphological features of loose fibrous connective tissue (LFCT) and myocardial contractility in patients with…
Expand
2012
2012
Long-term magnesium orotate therapy in patients with mitral valve prolapse
A. I. Martynov
,
A. Akatova
,
O. Nikolin
2012
Corpus ID: 208427097
year, were fol- ® (1500 mg/d) in three-month courses, twice a year, were fol- (1500 mg/d) in three-month courses, twice a year…
Expand
2010
2010
MAGNESIUM AND MITRAL VALVE PROLAPSE. EFFICACY AND THE POINTS OF APPLICATION
A. Avtandilov
,
K. M. Dzeranova
,
A. Pukhaeva
,
E. D. Manizer
2010
Corpus ID: 76252534
Mitral valve prolapse (MVP) is a manifestation of the hereditary syndrome of differentiated or undifferentiated connective tissue…
Expand
2010
2010
Comparable Cardioprotection at Reperfusion by Magnesium Orotate and Cyclosporin A: A Study in Isolated Rat Hearts
S. Mirica
2010
Corpus ID: 70651782
Orotic acid and its salts has been previously shown to improve the energy status of cardiomyocytes and to protect myocardium…
Expand
2005
2005
Clinical value of the use of magnesium orotate in adolescents with syndrome of cardiac connective tissue dysplasia
Domnitskaia Tm
,
D'iachenko Av
,
Kupriianova Oo
,
Domnitskiĭ Mv
2005
Corpus ID: 221230431
: According to results of clinical and instrumental investigation magnesium orotate (50 mg/day during first week and 25 mg/day…
Expand
2005
2005
[Clinical value of the use of magnesium orotate in adolescents with syndrome of cardiac connective tissue dysplasia].
T. M. Domnitskaia
,
A. V. Diachenko
,
O. O. Kupriianova
,
M. V. Domnitskiĭ
Kardiologiia
2005
Corpus ID: 38701391
According to results of clinical and instrumental investigation magnesium orotate (50 mg/day during first week and 25 mg/day…
Expand
2005
2005
[The place of diuretics in the treatment of chronic heart failure. Part I].
B. Sidorenko
,
D. V. Preobrazhenskiĭ
,
T. Batyraliev
,
I. Pershukov
,
S. A. Makhmutkhodzhaev
Kardiologiia
2005
Corpus ID: 27383809
In series of papers the authors analyze the literature data concerned with clinical pharmacology of four main classes of…
Expand
2002
2002
Unexpected toxicity induced by magnesium orotate treatment in congenital hypomagnesemia.
O. Guillard
,
A. Piriou
,
B. Fauconneau
,
G. Mauco
,
R. Mettey
Journal of Internal Medicine
2002
Corpus ID: 42796868
2000
2000
[New approaches to the treatment of patients with idiopathic mitral valve prolapse].
A. Martynov
,
O. Stepura
,
A. Shekhter
,
O. O. Mel'nik
,
L. Pak
,
T. Ushakova
Терапевтический архив
2000
Corpus ID: 44397148
AIM To assess efficiency of magnerot, magnesium orotate, in patients with idiopathic mitral prolapse (IMP). MATERIAL AND…
Expand
1998
1998
Effects of Magnesium Orotate on Exercise Tolerance in Patients with Coronary Heart Disease
K. Geiss
,
N. Stergiou
,
Jester
,
H. U. Neuenfeld
,
H. Jester
Cardiovascular Drugs and Therapy
1998
Corpus ID: 26575139
In a pilot study at 14 patients with coronary heart disease (CHD) and left-ventricular dysfunction (left ventricular enddiastolic…
Expand